Sunshine Biopharma (SBFM) Return on Assets [ROA] (2011 - 2026)
Sunshine Biopharma's Return on Assets [ROA] came in at -18.95% for Q2 2026, up 0.42 percentage points from -19.37% a year earlier and up 1.87 percentage points from the prior quarter.
Powered by 
Analysis
Sunshine Biopharma (SBFM) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2025, Sunshine Biopharma's Return on Assets [ROA] was -19.71%, down 1.98 percentage points from FY2024.
- Return on Assets [ROA] carries a five-year change of +467.18 percentage points (FY2020 to FY2025).
- Going back by year, Return on Assets [ROA] was -17.73% in FY2024 (-1.81 pp), -15.93% in FY2023 (+154.17 pp), -170.09% in FY2022 (+595.61 pp) and -765.71% in FY2021 (-278.81 pp).
- The five-year range for quarterly Return on Assets [ROA] is -656.98% (Q3 2021) to -8.57% (Q3 2022).
- Year-over-year, Return on Assets [ROA] increased in three of the last eight quarters, with an average year-over-year change of +7.62 percentage points.
- The fastest year-over-year change in Return on Assets [ROA] over five years came in Q3 2022 (a gain of 648.41 percentage points), and the weakest in Q4 2021 (a drop of 221.59 percentage points).
- Business Quant data shows SBFM's Return on Assets [ROA] at -20.82% (Q1 2026), -19.41% (Q4 2025) and -17.68% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 2.00% |
| 10 | Sunshine Biopharma | 187,731.50 | -38.90 Mn | 2.43 Mn | -18.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -18.95% |
| Mar 31, 2026 | -20.82% |
| Dec 31, 2025 | -19.41% |
| Sep 30, 2025 | -17.68% |
| Jun 30, 2025 | -19.37% |
| Mar 31, 2025 | -15.55% |
| Dec 31, 2024 | -15.85% |
| Sep 30, 2024 | -14.29% |
| Jun 30, 2024 | -12.11% |
| Mar 31, 2024 | -13.89% |
| Dec 31, 2023 | -16.29% |
| Sep 30, 2023 | -95.54% |
| Jun 30, 2023 | -99.54% |
| Mar 31, 2023 | -96.77% |
| Dec 31, 2022 | -76.29% |
| Sep 30, 2022 | -8.57% |
| Jun 30, 2022 | -22.13% |
| Mar 31, 2022 | -108.52% |
| Dec 31, 2021 | -570.47% |
| Sep 30, 2021 | -656.98% |
API Access
Sunshine Biopharma Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SBFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "SBFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SBFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();